...
首页> 外文期刊>The international journal of neuropsychopharmacology >A Network Meta-Analysis Comparing Effects of Various Antidepressant Classes on the Digit Symbol Substitution Test (DSST) as a Measure of Cognitive Dysfunction in Patients with Major Depressive Disorder
【24h】

A Network Meta-Analysis Comparing Effects of Various Antidepressant Classes on the Digit Symbol Substitution Test (DSST) as a Measure of Cognitive Dysfunction in Patients with Major Depressive Disorder

机译:网络荟萃分析比较各种抗抑郁药对数字符号替代测试(DSST)的作用,以评估重度抑郁症患者的认知功能障碍

获取原文
           

摘要

Background Major depressive disorder is a common condition that often includes cognitive dysfunction. A systematic literature review of studies and a network meta-analysis were carried out to assess the relative effect of antidepressants on cognitive dysfunction in major depressive disorder. Methods MEDLINE, Embase, Cochrane, CDSR, and PsychINFO databases; clinical trial registries; and relevant conference abstracts were searched for randomized controlled trials assessing the effects of antidepressants/placebo on cognition. A network meta-analysis comparing antidepressants was conducted using a random effects model. Results The database search retrieved 11337 citations, of which 72 randomized controlled trials from 103 publications met the inclusion criteria. The review identified 86 cognitive tests assessing the effect of antidepressants on cognitive functioning. However, the Digit Symbol Substitution Test, which targets multiple domains of cognition and is recognized as being sensitive to change, was the only test that was used across 12 of the included randomized controlled trials and that allowed the construction of a stable network suitable for the network meta-analysis. The interventions assessed included selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, and other non-selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors. The network meta-analysis using the Digit Symbol Substitution Test showed that vortioxetine was the only antidepressant that improved cognitive dysfunction on the Digit Symbol Substitution Test vs placebo {standardized mean difference: 0.325 (95% CI = 0.120; 0.529, P =.009}. Compared with other antidepressants, vortioxetine was statistically more efficacious on the Digit Symbol Substitution Test vs escitalopram, nortriptyline, and the selective serotonin reuptake inhibitor and tricyclic antidepressant classes. Conclusions This study highlighted the large variability in measures used to assess cognitive functioning. The findings on the Digit Symbol Substitution Test indicate differential effects of various antidepressants on improving cognitive function in patients with major depressive disorder. major depressive disorder , vortioxetine , cognitive dysfunction , systematic literature review , network meta-analysis Significance Statement Cognitive dysfunction is a common impairment for patients with major depressive disorder (MDD) and leads to debilitating problems such as missed workdays, poor academic performance, and reduced ability to perform day-to-day tasks. Numerous studies have investigated cognitive function in depression in a variety of domains, including attention, processing speed, executive function, and memory. Nevertheless, there is limited evidence on comparative effectiveness of antidepressants on cognitive symptoms, mainly due to the diversity of tools used in clinical trials. This study compared the effects of antidepressants on a commonly used cognitive outcome, the Digit Symbol Substitution Test (DSST), and showed that vortioxetine had the largest improvement in DSST vs all investigated classes of single antidepressants. It was the only antidepressant demonstrating statistically significant improvement vs placebo and vs specific antidepressants. The findings support the effect of vortioxetine in improving cognitive function in MDD patients measured by the DSST.
机译:背景严重的抑郁症是常见的疾病,通常包括认知功能障碍。进行了系统的文献综述研究和网络荟萃分析,以评估抗抑郁药对主要抑郁症认知功能障碍的相对影响。方法MEDLINE,Embase,Cochrane,CDSR和PsychINFO数据库;临床试验注册;检索相关会议摘要以评估抗抑郁药/安慰剂对认知的影响的随机对照试验。使用随机效应模型对抗抑郁药进行网络荟萃分析。结果数据库检索检索到11337次引用,其中来自103个出版物的72项随机对照试验符合纳入标准。该评价确定了86项认知测试,评估了抗抑郁药对认知功能的影响。但是,针对多个认知领域并且被认为对变化敏感的数字符号替代测试是唯一用于12项随机对照试验的测试,该测试可以构建一个适合于该领域的稳定网络。网络荟萃分析。评估的干预措施包括选择性5-羟色胺再摄取抑制剂,5-羟色胺-去甲肾上腺素再摄取抑制剂和其他非选择性5-羟色胺再摄取抑制剂/ 5-羟色胺-去甲肾上腺素再摄取抑制剂。使用数字符号替代测试的网络荟萃分析表明,伏洛西汀是唯一可以改善数字符号替代测试相对于安慰剂认知功能障碍的抗抑郁药{标准化平均差异:0.325(95%CI = 0.120; 0.529,P = .009}与其他抗抑郁药相比,伏立西汀在数字符号替代试验中与依他普仑,去甲替林和选择性5-羟色胺再摄取抑制剂和三环类抗抑郁药相比在统计学上更有效。数字符号替代测试的结果表明,各种抗抑郁药对重度抑郁症患者改善认知功能的影响不同。重度抑郁症,伏替西汀,认知功能障碍,系统文献综述,网络荟萃分析意义声明认知功能障碍是p的常见障碍患有严重抑郁症(MDD)的人,会导致令人虚弱的问题,例如工作日缺失,学习成绩差和执行日常任务的能力下降。许多研究已经研究了抑郁症在各个领域的认知功能,包括注意力,处理速度,执行功能和记忆。然而,关于抗抑郁药对认知症状的比较有效性的证据有限,这主要是由于临床试验中所用工具的多样性。这项研究比较了抗抑郁药对常用认知结局数字符号替代测试(DSST)的影响,并显示与所有研究类别的单一抗抑郁药相比,伏替西汀对DSST的改善最大。它是唯一显示出与安慰剂和特定抗抑郁药相比有统计学意义显着改善的抗抑郁药。这些发现支持了伏替西汀在改善DSDS测量的MDD患者认知功能中的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号